Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Evidence in Clinical Practice

Evidence in Clinical Practice EDITORIAL HE INSTITUTE OF MEDICINE (IOM), AGENCY by Archives Deputy Editor, Patrick G. O’Malley, MD, for Healthcare Research and Quality, Coch- MPH. O’Malley summarizes the findings of a report com- rane Collaboration, and other organiza- missioned by the Medicare Evidence Development and tions support the regular development of Coverage Advisory Committee of the Center for Medi- T high-quality evidence-based reviews of a care and Medicaid Services and conducted by the Insti- broad range of clinical topics. An excellent example is a tute for Clinical and Economic Review. This report com- report published in 2011 by the IOM titled Breast Can- pares the effectiveness of standard treatment of diabetic cer and the Environment: A Life Course Approach. This macular edema using laser photocoagulation with newer 468-page report available on the IOM website is a com- injectable intravitreal drugs that inhibit vascular endo- prehensive overview of current knowledge of the envi- thelial growth factor (VEGF). The findings suggest that ronmental causes of breast cancer. Because of the length the anti-VEGF drugs improve vision relative to laser pho- and unfamiliar format of the report, we believe our read- tocoagulation. ers are unlikely to be familiar with the findings. We invite the authors http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Evidence in Clinical Practice

JAMA Internal Medicine , Volume 172 (13) – Jul 9, 2012

Evidence in Clinical Practice

Abstract

EDITORIAL HE INSTITUTE OF MEDICINE (IOM), AGENCY by Archives Deputy Editor, Patrick G. O’Malley, MD, for Healthcare Research and Quality, Coch- MPH. O’Malley summarizes the findings of a report com- rane Collaboration, and other organiza- missioned by the Medicare Evidence Development and tions support the regular development of Coverage Advisory Committee of the Center for Medi- T high-quality evidence-based reviews of a care and Medicaid Services and conducted by the Insti-...
Loading next page...
 
/lp/american-medical-association/evidence-in-clinical-practice-W6yXzfi55R
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2012.2634
pmid
22688863
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL HE INSTITUTE OF MEDICINE (IOM), AGENCY by Archives Deputy Editor, Patrick G. O’Malley, MD, for Healthcare Research and Quality, Coch- MPH. O’Malley summarizes the findings of a report com- rane Collaboration, and other organiza- missioned by the Medicare Evidence Development and tions support the regular development of Coverage Advisory Committee of the Center for Medi- T high-quality evidence-based reviews of a care and Medicaid Services and conducted by the Insti- broad range of clinical topics. An excellent example is a tute for Clinical and Economic Review. This report com- report published in 2011 by the IOM titled Breast Can- pares the effectiveness of standard treatment of diabetic cer and the Environment: A Life Course Approach. This macular edema using laser photocoagulation with newer 468-page report available on the IOM website is a com- injectable intravitreal drugs that inhibit vascular endo- prehensive overview of current knowledge of the envi- thelial growth factor (VEGF). The findings suggest that ronmental causes of breast cancer. Because of the length the anti-VEGF drugs improve vision relative to laser pho- and unfamiliar format of the report, we believe our read- tocoagulation. ers are unlikely to be familiar with the findings. We invite the authors

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jul 9, 2012

References